Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 535-553, December 2007

Cannabinoid-1 receptor antagonists in type-2 diabetes

  • André J. Scheen, MD, PhD (Professor, Doctor)

      Affiliations

    • Corresponding Author InformationTel.: +32 43667238; Fax: +32 43667068.

Division of Diabetes, Nutrition and Metabolic Disorders, CHU Sart Tilman (B35), University of Liege, B 4000 Liege, Belgium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(07)00082-6

doi:10.1016/j.beem.2007.08.005

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 535-553, December 2007

Article Tools

* Image Usage & Resolution